Form 8-K - Current report:
SEC Accession No. 0001104659-24-007245
Filing Date
2024-01-26
Accepted
2024-01-26 16:07:55
Documents
13
Period of Report
2024-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244262d1_8k.htm   iXBRL 8-K 30271
  Complete submission text file 0001104659-24-007245.txt   247153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fbio-20240125.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20240125_def.xml EX-101.DEF 26650
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20240125_lab.xml EX-101.LAB 36691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20240125_pre.xml EX-101.PRE 25274
7 EXTRACTED XBRL INSTANCE DOCUMENT tm244262d1_8k_htm.xml XML 5170
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 24567793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)